Jaguar Animal Correlations
JAGX Stock | USD 1.00 0.03 2.91% |
The current 90-days correlation between Jaguar Animal Health and Onconova Therapeutics is -0.07 (i.e., Good diversification). The correlation of Jaguar Animal is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Jaguar Animal Correlation With Market
Average diversification
The correlation between Jaguar Animal Health and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Jaguar Animal Health and DJI in the same portfolio, assuming nothing else is changed.
Jaguar |
Moving together with Jaguar Stock
0.64 | LLY | Eli Lilly Buyout Trend | PairCorr |
0.67 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.71 | PDSB | PDS Biotechnology Corp | PairCorr |
0.75 | PEPG | PepGen | PairCorr |
Moving against Jaguar Stock
0.6 | PMVP | Pmv Pharmaceuticals | PairCorr |
0.52 | NAMS | NewAmsterdam Pharma | PairCorr |
0.51 | PHVS | Pharvaris BV | PairCorr |
0.47 | GILD | Gilead Sciences | PairCorr |
0.44 | LPTX | Leap Therapeutics | PairCorr |
0.43 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
0.39 | PLRX | Pliant Therapeutics | PairCorr |
0.79 | AGIO | Agios Pharm | PairCorr |
0.73 | SGMO | Sangamo Therapeutics Buyout Trend | PairCorr |
0.67 | VREX | Varex Imaging Corp | PairCorr |
0.59 | AVTE | Aerovate Therapeutics | PairCorr |
0.57 | CDXS | Codexis | PairCorr |
0.55 | CRVS | Corvus Pharmaceuticals | PairCorr |
0.35 | SYRE | Spyre Therapeutics Symbol Change | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Jaguar Stock performing well and Jaguar Animal Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Jaguar Animal's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ONTX | 4.73 | 1.02 | 0.15 | (0.58) | 4.35 | 7.69 | 66.73 | |||
IBIO | 3.76 | 0.43 | 0.09 | 0.98 | 3.54 | 7.76 | 30.48 | |||
GOVX | 5.88 | (1.17) | 0.00 | (0.43) | 0.00 | 9.26 | 77.95 | |||
OCGN | 3.18 | (0.77) | 0.00 | (0.28) | 0.00 | 8.08 | 18.12 | |||
EFTR | 7.57 | (4.61) | 0.00 | (14.08) | 0.00 | 8.70 | 88.91 | |||
VIRI | 5.85 | (0.36) | 0.00 | (5.81) | 0.00 | 12.46 | 50.54 | |||
ZURA | 3.89 | (0.58) | 0.00 | (0.15) | 0.00 | 7.95 | 26.70 | |||
NAVB | 6.04 | (1.19) | 0.00 | (1.62) | 0.00 | 12.50 | 40.40 | |||
ZVSA | 4.10 | (0.85) | 0.00 | 0.52 | 0.00 | 7.57 | 78.93 | |||
TNXP | 5.61 | (1.10) | 0.00 | (0.19) | 0.00 | 14.29 | 34.76 |
Jaguar Animal Corporate Management
Steven King | Executive VP of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary | Profile | |
DVM MS | VP Studies | Profile | |
Ian MBA | Chief Officer | Profile | |
Pravin Chaturvedi | Chief Board | Profile | |
Peter Hodge | Business Relations | Profile | |
Carol MBA | Chief Officer | Profile | |
Karen Brunke | Executive Development | Profile |